Drugs / VCL-IPM1
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00694213 | Aug 2007 → Sep 2008 | influenza | Vical | Completed | No outcome recorded |
| Phase 1 | NCT00709800 | Aug 2007 → Sep 2008 | influenza | Vical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VCL-IPM1 | “VCL-IPM1” NCT00694213 ↗ |
| Route | Intramuscular | “IM, 0.5 mg/mL, 2 injections, 0 and 21 days” NCT00694213 ↗ |